Roberto Mina, MD, details how in the MajesTEC-9 trial, teclistamab monotherapy boosted PFS and OS in relapsed/refractory multiple myeloma, challenging standardized care.

Researchers discovered that exposing cancer cells to vibration mimicking vocal cord movement reduced their malignancy.

Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...

Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive ...

Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged cells self-destruct. Across multiple labs, researchers are now converging on a ...

Iron is essential to biological function, and iron-based nanomaterials may become valuable tools in the long-term effort to ...

Even cells experience peer pressure. Scientists have long studied the ins and outs of cancer cells to learn more about the disease, but they're increasingly finding that noncancerous cells near the ...

Histological image of multiple myeloma in bone marrow: Degenerated plasma cells are stained purple. The image shows that they have almost completely displaced healthy cells. The large white cavities ...